X
XTL BIOPHARMACEUTICALS LTD
XTLBCIK 0001023549NasdaqNon-AcceleratedPharmaceutical PreparationsL3IL
Period
FY 2024
Revenue
—
Net Income
—
Total Assets
$8.55M
Equity
—
Shares Out
881.39M
Op. Cash Flow
—
Business
XTL BIOPHARMACEUTICALS LTD is a foreign private issuer in Pharmaceutical Preparations, headquartered in Israel. Shares trade on Nasdaq under the ticker XTLB.
Auto-generated from company profile
Financials
Latest annual snapshot (FY2024, period end 2024-12-31). Full statement history unavailable for this entity.
| Revenue | — |
| Net income | — |
| Total assets | $8.55M |
| Total liabilities | — |
| Stockholders' equity | — |
| Operating cash flow | — |
Filings
Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro
Material Events
Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro
Insiders
Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro
Institutional Holders
Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro